Phio Pharmaceuticals Corp (PHIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 32,745 | 14,294 | 16,918 | 18,914 | 13,334 |
| TOTAL | $33,322 | $15,164 | $17,620 | $19,554 | $13,601 |
| Non-Current Assets | |||||
| PPE Net | 145 | 157 | 173 | 183 | 202 |
| Other Non-Current Assets | 389 | 418 | 446 | 474 | 502 |
| TOTAL | $534 | $575 | $619 | $657 | $704 |
| Total Assets | $33,856 | $15,739 | $18,239 | $20,211 | $14,305 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 615 | 728 | 742 | 481 | 685 |
| Accrued Expenses | 1,458 | 1,352 | 1,375 | 1,301 | 1,143 |
| TOTAL | $2,191 | $2,196 | $2,230 | $1,893 | $1,937 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 231 | 231 | 231 | N/A |
| Other Non-Current Liabilities | 265 | 295 | 325 | 354 | 383 |
| TOTAL | $265 | $526 | $556 | $585 | $383 |
| Total Liabilities | $2,456 | $2,722 | $2,786 | $2,478 | $2,320 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 125 | 125 | 53 | 53 | 42 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -107,020 | -103,613 | -101,151 | -98,842 | -97,170 |
| TOTAL | $31,400 | $13,017 | $15,453 | $17,733 | $11,985 |
| Total Liabilities And Equity | $33,856 | $15,739 | $18,239 | $20,211 | $14,305 |